In 2013 he reported the first clinical use of catalytic DNA in human subjects This suggested that targeted catalytic DNA-based molecular therapy may represent a novel, effective and less invasive therapeutic option in humans.
In 2013 he reported the first clinical use of catalytic DNA in human subjects. Targeted catalytic DNA-based molecular therapy may represent a novel, effective and less invasive therapeutic approach in humans.